Skip to main content

Get Social

Facebook Posts

Join Ilana Stromberg and tell your Texas state legislators to pass Senate Bill 989 and House Bill 3188 to make insurers cover biomarker testing.Ilana, who is a mother to five children, was able to receive life saving precision cancer treatment as a direct result of biomarker testing.Many insurance companies aren't covering this game-changing testing for everyone who needs it, leaving it unaffordable for many patients. 66% of doctors who treat cancer report that insurance coverage is a barrier to utilizing this groundbreaking technology. Please take a few moments to tell your Texas Representative how critically important access to biomarker testing is for patients and ask them to support and coauthor the bill. Click the link below to write your Texas representative.tinyurl.com/ym9mv#txlegex#TXBiomarkersr#ACSCANTEXASt#biomarkertestings#hb3188B3188@drtomoliversontx ... See MoreSee Less
View on Facebook
Our latest blog post is out on our Nino News column, entitled "Understanding the Role of a Care Team in Treatment Planning!"Our guest blogger is Dr. Anthony “Nino” Sireci, M.D., senior vice president, clinical biomarker and diagnostics development, Loxo@Lilly. Check it out!happylungsproject.org/understanding-the-role-of-a-care-team-in-treatment-planning/ ... See MoreSee Less
View on Facebook

3 months ago

The Happy Lungs Project
Diagnosed with Lung Cancer Before the Age of 50? Help researchers crack the code!There's an urgent need for RET-positive cancer patients to participate in the Epidemiology of Lung Cancer Study, a clinical study for patients who were diagnosed with non-small cell lung cancer before age 50. The study aims to understand the differences between lung cancer in young and old patients including the presence of genetic mutations. RET-cancer patients are needed to understand the epidemiology and potential causes of the disease.tinyurl.com/2dkzy8b3 ... See MoreSee Less
View on Facebook
We love our supporters! 🧡💛❤️ Happy Valentine’s Day from The Happy Lungs Project ... See MoreSee Less
View on Facebook
HOPE!Ellipses Pharma Study to determine if a second generation RET inhibitor is a safe and possibly effective treatment for patients with RET-altered solid tumors.clinicaltrials.gov/ct2/show/NCT05443126 ... See MoreSee Less
View on Facebook